The sweet and sour of cancer: glycans as novel therapeutic targets

@article{Fuster2005TheSA,
  title={The sweet and sour of cancer: glycans as novel therapeutic targets},
  author={M. Fuster and J. Esko},
  journal={Nature Reviews Cancer},
  year={2005},
  volume={5},
  pages={526-542}
}
  • M. Fuster, J. Esko
  • Published 2005
  • Biology, Medicine
  • Nature Reviews Cancer
  • A growing body of evidence supports crucial roles for glycans at various pathophysiological steps of tumour progression. Glycans regulate tumour proliferation, invasion, haematogenous metastasis and angiogenesis, and increased understanding of these roles sets the stage for developing pharmaceutical agents that target these molecules. Such novel agents might be used alone or in combination with operative and/or chemoradiation strategies for treating cancer. 
    994 Citations

    Paper Mentions

    Cancer cell associated glycans as targets for immunotherapy
    • 7
    Multi-Glycomics Platform Approach for Cancer
    • 1
    Glycosylation in cancer: mechanisms and clinical implications
    • 993
    • PDF
    Glycans in Cancer
    • 20
    • Highly Influenced
    Alterations in glycosylation as biomarkers for cancer detection
    • 329
    Aiming at the sweet side of cancer: aberrant glycosylation as possible target for personalized-medicine.
    • 62
    • PDF
    Two opposing roles of O-glycans in tumor metastasis.
    • 47
    Glycosylation and Antitumor Immunity.
    • 2

    References

    SHOWING 1-10 OF 248 REFERENCES
    Targeting glycosylation as a therapeutic approach
    • 350
    Glycans in cancer and inflammation — potential for therapeutics and diagnostics
    • 1,223
    • Highly Influential
    • PDF
    Galectins as modulators of tumour progression
    • 1,137
    • PDF
    Mucins in cancer: protection and control of the cell surface
    • 1,417
    Glycosylation in Cellular Mechanisms of Health and Disease
    • 1,828
    • PDF
    The role of integrins in tumor angiogenesis.
    • 90
    Gangliosides as immunomodulators.
    • 33